ArticleFrontiers in oncology2024

Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients.

Yuya Hirasawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.